|Articles|May 2, 2023
AAN Annual Meeting 2023: Top Expert Interviews
Author(s)Isabella Ciccone, MPH
A group of experts in the care of patients with neurological conditions—Ali Jannati, MD, PhD; Madhav R. Thambisetty, MD, PhD; Daniel Ontaneda, MD, PhD; Peter J. Goadsby, MD, PhD, DSc; Andrew Russman, DO—shared their perspectives on hot topics of treatment and management in neurology from the 2023 American Academy of Neurology Annual Meeting.
Advertisement
The NeurologyLive® team has been as busy as always bringing you the latest clinical news and research updates in neurology over the last month, including conducting several interviews with experts across a number of different and varying topics.
This month, the team was on-site in Boston, Massachusetts, for the 2023 American Academy of Neurology Annual Meeting , providing live coverage of sessions and presentations from the floor of the convention center. While there, the team conducted a variety of sit-down interviews with experts about hot button issues and topics at the annual meeting. Those featured include:
- Ali Jannati, MD, PhD, manager of Clinical Development-Research at Linus Health
- Madhav R. Thambisetty, MD, PhD, senior investigator at the National Institute on Aging
- Daniel Ontaneda, MD, PhD, associate professor of neurology at the
Cleveland Clinic Lerner College of Medicine of Case Western University - Peter J. Goadsby, MD, PhD, DSc, professor of neurology at King’s College, London
- Andrew Russman, DO, medical director of the Comprehensive Stroke Center at
Cleveland Clinic
Click through the slides below to see and read more from each expert’s exclusive conversation with NeurologyLive® from AAN 2023:
—————————————————
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Expanding the Alzheimer Drug Development Pipeline
2
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4
NeurologyLive® Friday 5 — September 12, 2025
5